Legislation Would Address Fentanyl Epidemic 

Similar bills were introduced in both House and Senate. 

Representative Scott Fitzgerald of Wisconsin introduced a bill to address the ongoing opioid epidemic, particularly fentanyl-related substances. A Senate version is set to be introduced by Senator Ron Johnson of Wisconsin. 

The legislation, called the Stopping Overdoses of Fentanyl Analogues (SOFA) Act, would have fentanyl-related substances permanently designed as Schedule I drugs in the Controlled Substances Act. Under that act, “Schedule I drugs are those that have the following characteristic according to the United States Drug Enforcement Agency (DEA).” Current Schedule 1 drugs include heroin, LSD, marijuana, and khat among others. 

Prior to introducing the bill, Representative Fitzgerald said, “Drug overdose deaths have been climbing for years, and Fentanyl was the overwhelming driver of the record-breaking number of overdose deaths we experienced in 2021. Illicit versions of this dangerous substance are decimating our communities and the lives of loved ones struggling with drug addiction. It’s time for the federal government to wake up. We must take a stronger and more comprehensive approach to combat drug traffickers and get this drug off our streets.” 

Senator Johnson said, “Passing the SOFA Act is more important than ever as Americans face the worst border crisis in our nation’s history. This bill codifies an effective regulation that is preventing new fentanyl-related substances from entering our communities. Wisconsin families and American communities have been devastated by the opioid epidemic. I’m proud to work with Congressman Fitzgerald to re-introduce this lifesaving and common-sense legislation for the fourth time.” 

As the Lord Leads, Pray with Us…

  • For Senator Johnson and Representative Fitzgerald as they introduce the legislation to address the opioid crisis.
  • For members of Congress as they consider and discuss the provisions of the bills.
  • For Administrator Anne Milgram as she heads the DEA.

Sources: Daily Caller, Drugs.com, Drug Enforcement Administration 


Back to top